Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Effects of Pulmonary Rehabilitation on Function Cardiovascular, Respiratory and Functional Capacity of People With Chronic Obstructive Pulmonary Disease in the Municipality of Santa Cruz do Sul - Rio Grande do Sul.
The Chronic Obstructive Pulmonary Disease (COPD) has shown a progressive increase of morbidity and mortality, suggesting that the lung as a single therapeutic target, has not contributed in the past 20 years, significant changes to the natural evolution of the disease. Direct treatment for systemic changes and comorbidities, in fact, the most responsible for high rates of treatment failure could mean a new hope of life for individuals with COPD. This research project characterized as interdisciplinary and multidisciplinary program will be headquartered in Pulmonary Rehabilitation of the Santa Cruz Hospital which has partnerships with local companies . Its main objective will be to analyze cardiorespiratory and functional capacity in COPD patients not rehabilitated and rehabilitated after the period from 02 to 12 months of treatment in a Pulmonary Rehabilitation program in the municipality of Santa Cruz do Sul - Rio Grande do Sul. Will be included in this survey of COPD patients who were referred to a rehabilitation program with a clinical diagnosis of disease. In research activities to assess cardiorespiratory and functional capacity of COPD, pre and post-program (02 and 12 months) are provided for Pulmonary Rehabilitation. The research subjects will also be subjected to physical exercise protocol as recommended by the GOLD (2009), a period of eight weeks, often 2x / week, where their vital signs are measured before, during and after each session. Thus, it is believed that it will be possible to refine the knowledge of mechanisms by which the judicious use of pulmonary rehabilitation can control the progression of COPD.
Status | Active, not recruiting |
Enrollment | 70 |
Est. completion date | December 2016 |
Est. primary completion date | December 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 40 Years to 90 Years |
Eligibility |
Inclusion Criteria: - COPD patients with a clinical diagnosis Exclusion Criteria: - Motor sequelae of stroke, patients undergoing treatment for infectious diseases, musculoskeletal disorders that impede ambulation |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Universidade de Santa Cruz do Sul | Santa Cruz do Sul | Rio Grande do Sul |
Lead Sponsor | Collaborator |
---|---|
University of Santa Cruz do Sul |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Functional capacity in COPD patients | Will initially be evaluated after ten months. | Yes | |
Secondary | Ankle brachial index | The ankle brachial index is a noninvasive test used to evaluate the arterial blood flow in the lower limbs, is highly sensitive for the detection of peripheral arterial disease | Will be assessed after the admission of patients to pulmonary rehabilitation program. will be held after admission, subsequently after two and ten months | Yes |
Secondary | Window in ischemic lower limbs | Along with Ankle-Brachial Index, after the six-minute walk test will be rated at 2, 4 and 6 minutes after the test which may be obtained, or not, an ischemic curve in COPD patients | will be evaluated after functional testing submaximal. will be held after admission, subsequently after two and ten months | Yes |
Secondary | walk test six minutes | The test of six-minute walk test is a functional capacity and secondarily submaximal cardiovascular function, where the individual will need to walk for six minutes at maximum speed, without running. | will be conducted to evaluate rates of ischemic window by ankle brachial index, will be held after admission, subsequently after two and ten months | Yes |
Secondary | heart rate variability | The heart rate variability assesses the R-R curves of the electrocardiographic tracing of the heart using a heart rate monitor and is currently used to evaluate the sympathetic-vagal activity of the heart. In our study we use in all tests with patients (Astrand Protocol treadmill, Shuttle Walk Test and the Six Minute Walk Test) | will be held Durantes three tests: Shuttle Walk Test, test and six-minute walk incremental protocol in cycle rgometer. will be held after admission, subsequently after two and ten months | Yes |
Secondary | Shuttle Walk Test | Will be conducted to evaluate the functional capacity of the study participants. will be held after admission, subsequently after two and ten months | Yes | |
Secondary | Incremental protocol in cycle ergometer (Astrand Treadmill test) | The incremental Astrand Treadmill Test, is an incremental test on a cycle ergometer vertical predicts that the maximum capacity of an individual's body to transport and metabolize oxygen during incremental exercise. Together with this test will be evaluated index blood lactate every 3 minutes of testing. | will be held in conjunction with analysis of the lactate curve to assess the ability of resistance to fatigue of the participants, will be held after admission, subsequently after two and ten months | Yes |
Secondary | assessment of lung function | Lung function at digital spirometry assesses lung volumes through the forced vital capacity maneuver. Allows detecting obstructive, restrictive or mixed disorders. | will be held after the admission of patients to the project, will be held after admission, subsequently after two and ten months | Yes |
Secondary | assessment of respiratory muscle strength | Respiratory muscle strength will be assessed through maximal respiratory pressures test and helps assess maximal expiratory and inspiratory force through the pressures generated by the patient. This test evaluates jointly the inspiratory muscles, and likewise the expiratory muscles. | will be held after admission, subsequently after two and ten months | Yes |
Secondary | assessment of handgrip strength | The grip strength will be assessed by hydraulic handgrip dynamometer. It is a test that evaluates the strength of the handshake individual and quantifies overall muscle strength. | will be held after admission, subsequently after two and ten months | Yes |
Secondary | assessment of quality of life | The quality of life will be assessed through the questionnaire Saint George's Respiratory Questionnaire. It is created and validated a questionnaire focused for patients with respiratory diseases. | will be held after admission, subsequently after two and ten months | Yes |
Secondary | assessment of the economic and social level | The socioeconomic level of the individuals will be assessed by the Brazilian Association of Research Companies survey. It is a questionnaire created in Brazil to quantify the economic track of the Brazilian population specifically. | will be evaluated only once | Yes |
Secondary | classification of patients as BODE index | The BODE index is an index that assesses the health status of patients with COPD. It consists of four items (B - measured by body mass index or "body mass in-dex" (weight / height); O - obstruction as measured by FEV1 (forced expiratory volume in one second); D - measured by degree of dyspnea; E - exercise, assessed by using the 6-minute walk) | Will be assessed at baseline (start of pulmonary rehabilitation) and after 10 months (final evaluation) | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|